Phase 3 Adherence Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
STI Testing to Enhance PrEP Use in Pregnancy
PregnancySexually Transmitted Infections (STIs)PrEP Adherence
Botswana Harvard AIDS Institute Partnership600 enrolled1 locationNCT06919614
Recruiting
Phase 3
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
HIV InfectionsSubstance UseAdherence, Treatment+1 more
Brigham and Women's Hospital40 enrolled1 locationNCT05378399
Recruiting
Phase 3
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
HIV InfectionsAdherence, Medication
University of Illinois at Chicago126 enrolled1 locationNCT06550804
Recruiting
Phase 3
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
HIV-1-infectionNon-Adherence, Medication
Chang Gung Memorial Hospital40 enrolled4 locationsNCT06507059
Completed
Phase 3
The Kanyini Guidelines Adherence with the Polypill Study- A clinical trial to investigate whether a fixed dose combination 'Polypill' Medication is better than existing treatments for people at high risk of cardiovascular disease.
Medication AdherenceHigh Risk Cardiovascular Disease
The George Institute for Global Health1,000 enrolled1 locationACTRN12608000583347